Foundation Medicine on X: "Get info about MSI, TMB and >300 cancer-related genes in a single test with FoundationOne®. #ASCO17 https://t.co/SRGCzrQA88" / X
![Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer | Molecular Diagnosis & Therapy Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer | Molecular Diagnosis & Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40291-019-00408-y/MediaObjects/40291_2019_408_Fig5_HTML.png)
Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer | Molecular Diagnosis & Therapy
![Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience](https://www.frontiersin.org/files/Articles/687730/fonc-11-687730-HTML/image_m/fonc-11-687730-t004.jpg)
Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience
![U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca's Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer | Business Wire U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca's Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer | Business Wire](https://mms.businesswire.com/media/20231120975726/en/794671/22/FMI_horizontal.jpg)
U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca's Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer | Business Wire
![profiling results from FoundationOne™ testing. 73 deleterious mutations... | Download Scientific Diagram profiling results from FoundationOne™ testing. 73 deleterious mutations... | Download Scientific Diagram](https://www.researchgate.net/publication/286403721/figure/tbl1/AS:613937913528376@1523385613971/profiling-results-from-FoundationOne-testing-73-deleterious-mutations-were-identified.png)